​
Positron Emission Tomography (PET) is a medical imaging technique that uses tiny amounts of radioactive tracers to evaluate the levels of specific proteins present in the brain. 

At the DCPR we use PET scanning combined with cutting edge analysis techniques to evaluate how psychedelic drugs bind to receptors in the brain as well as to evaluate neurochemical changes following psychedelic administration. These experiments can inform more exactly how psychedelics exert their effects and drive drug development for more effective therapeutics.